entreprises – Accord tripartite État, Sanofi et CD&R

This written question concerns a tripartite agreement between the French State, the pharmaceutical company Sanofi, and the investment firm CD&R. It likely seeks clarification on the terms, implications, or public interest aspects of this specific deal. The question affects the pharmaceutical sector and potentially public health policy. It may also involve scrutiny of state involvement in private company agreements and investment.